Vestibular migraine: A case report and review of the literature

Vestibular migraine (VM) is one of the most common causes of episodic vertigo, but it can be missed in patients complaining of dizziness. This report describes the case of a 46-year-old woman with episodic vertigo attacks and a history of migrainous headaches. Some of the vertigo attacks were accompanied by a migraine. Gaze-induced nystagmus was present during attacks, but regressed with medication. Ear, nose, and throat evaluation; laboratory; imaging findings; and hearing test results were normal. Treatment with 500 mg valproic acid led to a rapid response in this case. VM should be considered in neurological examinations on the basis of clinical symptomatology.

Vestibuler migren: Olgu sunumu ve literatürün gözden geçirilmesi

Vestibuler migren epizodik vertigonun en sık nedenlerinden biridir ancak başdönmesi yakınmalarına sahip olgularda vestibüler migren tanısı atlanabilmektedir. Bu yazıda epizodik vertigo atakları ve özgeçmişinde migrenöz başağrıları olan 46 yaşında kadın olguyu sunmayı amaçladık. Vertigo ataklarının bazılarına migrenöz vasıfta başağrısı eşlik ediyordu. Nörolojik değerlendirmesinde atak döneminde bakış ile indüklenen nistagmusu olup atak dışında normaldi. Kulak burun boğaz değerlendirmesi, laboratuar ve görüntüleme çalışmaları ile işitme testi normaldi. Klinik semptomatoloji temelinde vestibüler migren tanısı düşünüldü. Tedavide 500 mg valproik asit ile hızlı yanıt alındı.

PDF

___

1. Sohn JH. Recent Advances in the Understanding of Vestibular Migraine. Behav Neurol 2016;2016:1801845.

2. Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res 2012;22(4):167–72.

3. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33(9):629–808.

4. Lee H, Jen JC, Cha YH, Nelson SF, Baloh RW. Phenotypic and genetic analysis of a large family with migraine-associated vertigo. Headache 2008;48(10):1460–7.

5. Bahmad F Jr, DePalma SR, Merchant SN, Bezerra RL, Oliveira CA, Seidman CE, et al. Locus for familial migrainous vertigo disease maps to chromosome 5q35. Ann Otol Rhinol Laryngol 2009;118(9):670–6.

6. O’Connell Ferster AP, Priesol AJ, Isildak H. The clinical manifestations of vestibular migraine: A review. Auris Nasus Larynx. 2017;44(3):249–52.

7. Munro-Porchet S. Supportive care in cancer patients, 2nd International Symposium, St. Gallen, Switzerland--March 1-3, 1990. J Palliat Care 1990;6(3):45–6.

8. Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. J Neurol 2016;263(Suppl 1):S82–9.

9. Polensek SH, Tusa RJ. Nystagmus during attacks of vestibular migraine: an aid in diagnosis. Audiol Neurootol 2010;15(4):241–6.

10. Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol 2013;12(7):706–15.

11. Wang CT, Lai MS, Young YH. Relationship between basilar-type migraine and migrainous vertigo. Headache 2009;49(3):426–34.

12. Radtke A, Lempert T, Gresty MA, Brookes GB, Bronstein AM, Neuhauser H. Migraine and Ménière’s disease: is there a link? Neurology 2002;59(11):1700–4.

13. Barbosa F, Villa TR. Vestibular migraine: diagnosis challenges and need for targeted treatment. Arq Neuropsiquiatr 2016;74(5):416–22.

14. Lauritsen CG, Marmura MJ. Current Treatment Options: Vestibular Migraine. Curr Treat Options Neurol 2017;19(11):38.

15. Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol 1997;18(3):350–4.

16. Prakash S, Shah ND. Migrainous vertigo responsive to intravenous methylprednisolone: case reports. Headache 2009;49(8):1235–9.

17. Salmito MC, Duarte JA, Morganti LOG, Brandão PVC, Nakao BH, Villa TR, et al. Prophylactic treatment of vestibular migraine. Braz J Otorhinolaryngol 2017;83(4):404–10.

18. Fotuhi M, Glaun B, Quan SY, Sofare T. Vestibular migraine: a critical review of treatment trials. J Neurol 2009;256(5):711– 6.

19. Celiker A, Bir LS, Ardiç N. Effects of valproate on vestibular symptoms and electronystagmographic findings in migraine patients. Clin Neuropharmacol 2007;30(4):213–7.

20. Liu F, Ma T, Che X, Wang Q, Yu S. The Efficacy of Venlafaxine, Flunarizine, and Valproic Acid in the Prophylaxis of Vestibular Migraine. Front Neurol 2017;8:524.